Depressive disorders in childhood and adolescence - an analysis of KinderAGATE 2010
The present analysis evaluates the prevalence and medication use in inpatients with depression during childhood and adolescence at the KinderAGATE hospitals in 2010. Also discussed are age and sex distribution. Since 2009 the following information has been recorded anonymously twice a year from each...
Gespeichert in:
| Veröffentlicht in: | Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 2013-03, Vol.41 (2), p.109-119 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 119 |
|---|---|
| container_issue | 2 |
| container_start_page | 109 |
| container_title | Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie |
| container_volume | 41 |
| creator | Stegmann, Benedikt Wenzel-Seifert, Katharina Haen, Ekkehard |
| description | The present analysis evaluates the prevalence and medication use in inpatients with depression during childhood and adolescence at the KinderAGATE hospitals in 2010. Also discussed are age and sex distribution.
Since 2009 the following information has been recorded anonymously twice a year from each patient at the participating hospitals of KinderAGATE: age, sex, leading diagnosis, prescribed medication and dosage. The data obtained provide an excellent epidemiological basis for the observation of the prescription practice in child and adolescent psychiatry.
In 2010, 8.4 % of the patients included were treated for a depressive disorder at the KinderAGATE hospitals. This is only a small portion compared to the rates found in adult psychiatry (25.8 % of patients). In our sample male patients diagnosed with depression (58 % DPat, mean age 13.8 years) were treated more often and earlier than female patients (42 % DPat, mean age 15.3 years). Fluoxetine and mirtazapine were the most frequently prescribed substances. Sertraline, escitalopram, and citalopram were also prescribed.
A reserved medical treatment can be observed in child and adolescence psychiatry. Off-label use seems to be nearly unavoidable due to the lack of newly authorized medicine. Moreover, the numerous prescriptions for fluoxetine, the only SSRI currently approved for this age group in Germany, lead to the question of possible unauthorized alternatives. |
| doi_str_mv | 10.1024/1422-4917/a000218 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1312171495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1312171495</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-d33867ea79a82966f10b911c9040f89414f07c672d3c54eee7e00a82150facbc3</originalsourceid><addsrcrecordid>eNo9kEFLAzEQhXNQbK3-AC-So5e1M0k22T2W2lax4MF6XtJklka2u-umFfrvDViFGQYe3zwej7E7hEcEoaaohMhUiWZqAUBgccHG_9qIXcf4CaB1AeKKjYRUItcox-z9ifqBYgzfxH2I3eBpiDy03O1C43dd57lt0_quoeiodcSzpKSxzSmGyLuav4Y2fc1Ws82CC0C4YZe1bSLdnu-EfSwXm_lztn5bvcxn66xHhYfMS1loQ9aUthCl1jXCtkR0JSioi1KhqsE4bYSXLldEZAggoZhDbd3WyQl7-PXth-7rSPFQ7UPK2DS2pe4YK5Qo0KAq84Ten9Hjdk--6oewt8Op-itC_gBu41vQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1312171495</pqid></control><display><type>article</type><title>Depressive disorders in childhood and adolescence - an analysis of KinderAGATE 2010</title><source>MEDLINE</source><source>Hogrefe eContent</source><creator>Stegmann, Benedikt ; Wenzel-Seifert, Katharina ; Haen, Ekkehard</creator><creatorcontrib>Stegmann, Benedikt ; Wenzel-Seifert, Katharina ; Haen, Ekkehard</creatorcontrib><description>The present analysis evaluates the prevalence and medication use in inpatients with depression during childhood and adolescence at the KinderAGATE hospitals in 2010. Also discussed are age and sex distribution.
Since 2009 the following information has been recorded anonymously twice a year from each patient at the participating hospitals of KinderAGATE: age, sex, leading diagnosis, prescribed medication and dosage. The data obtained provide an excellent epidemiological basis for the observation of the prescription practice in child and adolescent psychiatry.
In 2010, 8.4 % of the patients included were treated for a depressive disorder at the KinderAGATE hospitals. This is only a small portion compared to the rates found in adult psychiatry (25.8 % of patients). In our sample male patients diagnosed with depression (58 % DPat, mean age 13.8 years) were treated more often and earlier than female patients (42 % DPat, mean age 15.3 years). Fluoxetine and mirtazapine were the most frequently prescribed substances. Sertraline, escitalopram, and citalopram were also prescribed.
A reserved medical treatment can be observed in child and adolescence psychiatry. Off-label use seems to be nearly unavoidable due to the lack of newly authorized medicine. Moreover, the numerous prescriptions for fluoxetine, the only SSRI currently approved for this age group in Germany, lead to the question of possible unauthorized alternatives.</description><identifier>ISSN: 1422-4917</identifier><identifier>DOI: 10.1024/1422-4917/a000218</identifier><identifier>PMID: 23425613</identifier><language>ger</language><publisher>Switzerland</publisher><subject>Adolescent ; Adolescent Psychiatry ; Antidepressive Agents - adverse effects ; Antidepressive Agents - therapeutic use ; Child ; Child Psychiatry - education ; Child, Preschool ; Combined Modality Therapy ; Databases, Factual ; Depressive Disorder - diagnosis ; Depressive Disorder - drug therapy ; Depressive Disorder - epidemiology ; Depressive Disorder - psychology ; Dose-Response Relationship, Drug ; Education, Medical, Continuing ; Evidence-Based Medicine ; Female ; Follow-Up Studies ; Germany ; Hospitalization - statistics & numerical data ; Humans ; Infant ; Inservice Training ; Male ; Off-Label Use - statistics & numerical data ; Patient Admission ; Practice Patterns, Physicians' - statistics & numerical data ; Psychotherapy ; Quality Assurance, Health Care ; Societies, Hospital ; Young Adult</subject><ispartof>Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 2013-03, Vol.41 (2), p.109-119</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23425613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stegmann, Benedikt</creatorcontrib><creatorcontrib>Wenzel-Seifert, Katharina</creatorcontrib><creatorcontrib>Haen, Ekkehard</creatorcontrib><title>Depressive disorders in childhood and adolescence - an analysis of KinderAGATE 2010</title><title>Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie</title><addtitle>Z Kinder Jugendpsychiatr Psychother</addtitle><description>The present analysis evaluates the prevalence and medication use in inpatients with depression during childhood and adolescence at the KinderAGATE hospitals in 2010. Also discussed are age and sex distribution.
Since 2009 the following information has been recorded anonymously twice a year from each patient at the participating hospitals of KinderAGATE: age, sex, leading diagnosis, prescribed medication and dosage. The data obtained provide an excellent epidemiological basis for the observation of the prescription practice in child and adolescent psychiatry.
In 2010, 8.4 % of the patients included were treated for a depressive disorder at the KinderAGATE hospitals. This is only a small portion compared to the rates found in adult psychiatry (25.8 % of patients). In our sample male patients diagnosed with depression (58 % DPat, mean age 13.8 years) were treated more often and earlier than female patients (42 % DPat, mean age 15.3 years). Fluoxetine and mirtazapine were the most frequently prescribed substances. Sertraline, escitalopram, and citalopram were also prescribed.
A reserved medical treatment can be observed in child and adolescence psychiatry. Off-label use seems to be nearly unavoidable due to the lack of newly authorized medicine. Moreover, the numerous prescriptions for fluoxetine, the only SSRI currently approved for this age group in Germany, lead to the question of possible unauthorized alternatives.</description><subject>Adolescent</subject><subject>Adolescent Psychiatry</subject><subject>Antidepressive Agents - adverse effects</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Child</subject><subject>Child Psychiatry - education</subject><subject>Child, Preschool</subject><subject>Combined Modality Therapy</subject><subject>Databases, Factual</subject><subject>Depressive Disorder - diagnosis</subject><subject>Depressive Disorder - drug therapy</subject><subject>Depressive Disorder - epidemiology</subject><subject>Depressive Disorder - psychology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Education, Medical, Continuing</subject><subject>Evidence-Based Medicine</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Germany</subject><subject>Hospitalization - statistics & numerical data</subject><subject>Humans</subject><subject>Infant</subject><subject>Inservice Training</subject><subject>Male</subject><subject>Off-Label Use - statistics & numerical data</subject><subject>Patient Admission</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>Psychotherapy</subject><subject>Quality Assurance, Health Care</subject><subject>Societies, Hospital</subject><subject>Young Adult</subject><issn>1422-4917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEFLAzEQhXNQbK3-AC-So5e1M0k22T2W2lax4MF6XtJklka2u-umFfrvDViFGQYe3zwej7E7hEcEoaaohMhUiWZqAUBgccHG_9qIXcf4CaB1AeKKjYRUItcox-z9ifqBYgzfxH2I3eBpiDy03O1C43dd57lt0_quoeiodcSzpKSxzSmGyLuav4Y2fc1Ws82CC0C4YZe1bSLdnu-EfSwXm_lztn5bvcxn66xHhYfMS1loQ9aUthCl1jXCtkR0JSioi1KhqsE4bYSXLldEZAggoZhDbd3WyQl7-PXth-7rSPFQ7UPK2DS2pe4YK5Qo0KAq84Ten9Hjdk--6oewt8Op-itC_gBu41vQ</recordid><startdate>201303</startdate><enddate>201303</enddate><creator>Stegmann, Benedikt</creator><creator>Wenzel-Seifert, Katharina</creator><creator>Haen, Ekkehard</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201303</creationdate><title>Depressive disorders in childhood and adolescence - an analysis of KinderAGATE 2010</title><author>Stegmann, Benedikt ; Wenzel-Seifert, Katharina ; Haen, Ekkehard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-d33867ea79a82966f10b911c9040f89414f07c672d3c54eee7e00a82150facbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adolescent Psychiatry</topic><topic>Antidepressive Agents - adverse effects</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Child</topic><topic>Child Psychiatry - education</topic><topic>Child, Preschool</topic><topic>Combined Modality Therapy</topic><topic>Databases, Factual</topic><topic>Depressive Disorder - diagnosis</topic><topic>Depressive Disorder - drug therapy</topic><topic>Depressive Disorder - epidemiology</topic><topic>Depressive Disorder - psychology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Education, Medical, Continuing</topic><topic>Evidence-Based Medicine</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Germany</topic><topic>Hospitalization - statistics & numerical data</topic><topic>Humans</topic><topic>Infant</topic><topic>Inservice Training</topic><topic>Male</topic><topic>Off-Label Use - statistics & numerical data</topic><topic>Patient Admission</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>Psychotherapy</topic><topic>Quality Assurance, Health Care</topic><topic>Societies, Hospital</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stegmann, Benedikt</creatorcontrib><creatorcontrib>Wenzel-Seifert, Katharina</creatorcontrib><creatorcontrib>Haen, Ekkehard</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stegmann, Benedikt</au><au>Wenzel-Seifert, Katharina</au><au>Haen, Ekkehard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depressive disorders in childhood and adolescence - an analysis of KinderAGATE 2010</atitle><jtitle>Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie</jtitle><addtitle>Z Kinder Jugendpsychiatr Psychother</addtitle><date>2013-03</date><risdate>2013</risdate><volume>41</volume><issue>2</issue><spage>109</spage><epage>119</epage><pages>109-119</pages><issn>1422-4917</issn><abstract>The present analysis evaluates the prevalence and medication use in inpatients with depression during childhood and adolescence at the KinderAGATE hospitals in 2010. Also discussed are age and sex distribution.
Since 2009 the following information has been recorded anonymously twice a year from each patient at the participating hospitals of KinderAGATE: age, sex, leading diagnosis, prescribed medication and dosage. The data obtained provide an excellent epidemiological basis for the observation of the prescription practice in child and adolescent psychiatry.
In 2010, 8.4 % of the patients included were treated for a depressive disorder at the KinderAGATE hospitals. This is only a small portion compared to the rates found in adult psychiatry (25.8 % of patients). In our sample male patients diagnosed with depression (58 % DPat, mean age 13.8 years) were treated more often and earlier than female patients (42 % DPat, mean age 15.3 years). Fluoxetine and mirtazapine were the most frequently prescribed substances. Sertraline, escitalopram, and citalopram were also prescribed.
A reserved medical treatment can be observed in child and adolescence psychiatry. Off-label use seems to be nearly unavoidable due to the lack of newly authorized medicine. Moreover, the numerous prescriptions for fluoxetine, the only SSRI currently approved for this age group in Germany, lead to the question of possible unauthorized alternatives.</abstract><cop>Switzerland</cop><pmid>23425613</pmid><doi>10.1024/1422-4917/a000218</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-4917 |
| ispartof | Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 2013-03, Vol.41 (2), p.109-119 |
| issn | 1422-4917 |
| language | ger |
| recordid | cdi_proquest_miscellaneous_1312171495 |
| source | MEDLINE; Hogrefe eContent |
| subjects | Adolescent Adolescent Psychiatry Antidepressive Agents - adverse effects Antidepressive Agents - therapeutic use Child Child Psychiatry - education Child, Preschool Combined Modality Therapy Databases, Factual Depressive Disorder - diagnosis Depressive Disorder - drug therapy Depressive Disorder - epidemiology Depressive Disorder - psychology Dose-Response Relationship, Drug Education, Medical, Continuing Evidence-Based Medicine Female Follow-Up Studies Germany Hospitalization - statistics & numerical data Humans Infant Inservice Training Male Off-Label Use - statistics & numerical data Patient Admission Practice Patterns, Physicians' - statistics & numerical data Psychotherapy Quality Assurance, Health Care Societies, Hospital Young Adult |
| title | Depressive disorders in childhood and adolescence - an analysis of KinderAGATE 2010 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T10%3A38%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depressive%20disorders%20in%20childhood%20and%20adolescence%20-%20an%20analysis%20of%20KinderAGATE%202010&rft.jtitle=Zeitschrift%20f%C3%BCr%20Kinder-%20und%20Jugendpsychiatrie%20und%20Psychotherapie&rft.au=Stegmann,%20Benedikt&rft.date=2013-03&rft.volume=41&rft.issue=2&rft.spage=109&rft.epage=119&rft.pages=109-119&rft.issn=1422-4917&rft_id=info:doi/10.1024/1422-4917/a000218&rft_dat=%3Cproquest_pubme%3E1312171495%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1312171495&rft_id=info:pmid/23425613&rfr_iscdi=true |